All In MedTech

Device Trial Radar · NCT07559708

A Study of the Sleepnet Elara APAP Device

A Prospective, Open-label Study to Assess the Efficacy of the Elara APAP Device When Used in Patients With Obstructive Sleep Apnea

Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

89

Actual

Start

Apr 21, 2026

Primary completion

Oct 20, 2026

Study completion Oct 20, 2026

Sponsor

Lead sponsor
Sleepnet CorporationNot on our public-company list
Sponsor type
Industry
First posted
Apr 30, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this study is to evaluate the effectiveness of the Elara APAP device.

Conditions

  • Sleep Apnea - Obstructive

Interventions

  • Sleepnet Elara TreatmentDevice

    Subject to have a 1 night in-lab PSG

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. AHI 4%Time frame: Day 1

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • University Sleep Disorders Center

    Auburn, Alabama

  • Clayton Sleep Institute

    St Louis, Missouri

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.